Aminolevulinic acid hydrochloride is under clinical development by Photonamic and currently in Phase II for Colorectal Cancer.

Surgery was the most effective treatment for cutaneous squamous cell carcinoma in situ, however, variations among other treatment approaches exist.

"Results from this investigation suggest that the half-light dose protocol using BF-200 ALA PDT is not only effective but ...

Rising Pharmaceuticals, Inc. announces commercial availability of Edetate calcium disodium injection in the United States ...

Aminolevulinic acid hydrochloride is under clinical development by Photonamic and currently in Phase III for Ovarian Cancer.